Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
dc.contributor.author | Karacin, C | |
dc.contributor.author | Oksuzoglu, B | |
dc.contributor.author | Demirci, A | |
dc.contributor.author | Keskinkiliç, M | |
dc.contributor.author | Baytemür, NK | |
dc.contributor.author | Yilmaz, F | |
dc.contributor.author | Selvi, O | |
dc.contributor.author | Erdem, D | |
dc.contributor.author | Avsar, E | |
dc.contributor.author | Paksoy, N | |
dc.contributor.author | Demir, N | |
dc.contributor.author | Göksu, SS | |
dc.contributor.author | Türker, S | |
dc.contributor.author | Bayram, E | |
dc.contributor.author | Çelebi, A | |
dc.contributor.author | Yilmaz, H | |
dc.contributor.author | Kuzu, ÖF | |
dc.contributor.author | Kahraman, S | |
dc.contributor.author | Gökmen, I | |
dc.contributor.author | Sakin, A | |
dc.contributor.author | Alkan, A | |
dc.contributor.author | Nayir, E | |
dc.contributor.author | Ugrakli, M | |
dc.contributor.author | Acar, Ö | |
dc.contributor.author | Ertürk, I | |
dc.contributor.author | Demir, H | |
dc.contributor.author | Aslan, F | |
dc.contributor.author | Sönmez, Ö | |
dc.contributor.author | Korkmaz, T | |
dc.contributor.author | Celayir, ÖM | |
dc.contributor.author | Karadag, I | |
dc.contributor.author | Kayikçioglu, E | |
dc.contributor.author | Sakalar, T | |
dc.contributor.author | Öktem, IN | |
dc.contributor.author | Eren, T | |
dc.contributor.author | Erul, E | |
dc.contributor.author | Mocan, EE | |
dc.contributor.author | Kalkan, Z | |
dc.contributor.author | Yildirim, N | |
dc.contributor.author | Ergün, Y | |
dc.contributor.author | Akagündüz, B | |
dc.contributor.author | Karakaya, S | |
dc.contributor.author | Kut, E | |
dc.contributor.author | Teker, F | |
dc.contributor.author | Demirel, BÇ | |
dc.contributor.author | Karaboyun, K | |
dc.contributor.author | Almuradova, E | |
dc.contributor.author | Ünal, OÜ | |
dc.contributor.author | Oyman, A | |
dc.contributor.author | Isik, D | |
dc.contributor.author | Okutur, K | |
dc.contributor.author | Öztosun, B | |
dc.contributor.author | Gülbagci, BB | |
dc.contributor.author | Kalender, ME | |
dc.contributor.author | Sahin, E | |
dc.contributor.author | Seyyar, M | |
dc.contributor.author | Özdemir, Ö | |
dc.contributor.author | Selçukbiricik, F | |
dc.contributor.author | Kanitez, M | |
dc.contributor.author | Dede, I | |
dc.contributor.author | Gümüs, M | |
dc.contributor.author | Gökmen, E | |
dc.contributor.author | Yaren, A | |
dc.contributor.author | Menekse, S | |
dc.contributor.author | Ebinç, S | |
dc.contributor.author | Aksoy, S | |
dc.contributor.author | Imamoglu, GI | |
dc.contributor.author | Altinbas, M | |
dc.contributor.author | Çetin, B | |
dc.contributor.author | Uluç, BO | |
dc.contributor.author | Er, Ö | |
dc.contributor.author | Karadurmus, N | |
dc.contributor.author | Erdogan, AP | |
dc.contributor.author | Artaç, M | |
dc.contributor.author | Tanriverdi, Ö | |
dc.contributor.author | Çiçin, I | |
dc.contributor.author | Sendur, MAN | |
dc.contributor.author | Oktay, E | |
dc.contributor.author | Bayoglu, IV | |
dc.contributor.author | Paydas, S | |
dc.contributor.author | Aydiner, A | |
dc.contributor.author | Salim, DK | |
dc.contributor.author | Geredeli, Ç | |
dc.contributor.author | Yavuzsen, T | |
dc.contributor.author | Dogan, M | |
dc.contributor.author | Hacibekiroglu, I | |
dc.date.accessioned | 2024-07-18T12:08:41Z | |
dc.date.available | 2024-07-18T12:08:41Z | |
dc.identifier.other | 1471-2407 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11040 | |
dc.language.iso | English | |
dc.publisher | BMC | |
dc.title | Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023) | |
dc.type | Correction |